Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000292

Drug Information
SynonymsMolPort-006-389-303; su5614; SU-5614; CID6536806; (3Z)-5-chloro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one; C416849; 5-Chloro-3-[(3,5-dimethylpyrrol-2-yl)methylene]-2-indolinone; SU 5614; AC1O6W2Q
CompanySugen Pharmaceuticals
IndicationAirway inflammation
[ICD9: 460-519   ICD10: J00-J99]
Phase I/II    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC1=CC(=C(N1)C=C2C3=C(C=CC(=C3)Cl)NC2=O)C    
Isomeric SMILESCC1=CC(=C(N1)/C=C\2/C3=C(C=CC(=C3)Cl)NC2=O)C
CAS NumberCAS 186611-56-3
PubChem Compound IDCID 6536806.
PubChem Substance IDSID 11643921.
TargetFL cytokine receptorInhibitor[1]
Ref 1FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro. Cancer Res. 2009 Apr 1;69(7):3032-41. Epub 2009 Mar 24. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543